Figures & data
Figure 1. Working Group 4 research priorities for the health of people who have or had the potential to menstruate schematic of community-identified areas for priority research framework.
![Figure 1. Working Group 4 research priorities for the health of people who have or had the potential to menstruate schematic of community-identified areas for priority research framework.](/cms/asset/63751479-b055-4c11-bddc-0150fc530ddb/ierr_a_2175660_f0001_c.jpg)
Table 1. Members of working group 4.
Figure 2. Six focused research domains identified by WG4, and the core issues examined for each.
![Figure 2. Six focused research domains identified by WG4, and the core issues examined for each.](/cms/asset/ddca2833-ffb1-4f22-87ba-1ab774625aac/ierr_a_2175660_f0002_c.jpg)
Figure 3. Plot of feasibility, impact, and risk scores of prioritized questions in each focused research domain.
![Figure 3. Plot of feasibility, impact, and risk scores of prioritized questions in each focused research domain.](/cms/asset/3a30dfa8-43be-414d-98bf-c1ca4fc5bc15/ierr_a_2175660_f0003_c.jpg)
Figure 4. Venn diagrams of areas of impact of the prioritized research questions in each focused research domain a. Lifespan sex biology b. Pregnancy and the post-partum context c. Uterine physiology and bleeding research questions d. Bone and joint health e. Health care delivery f. Patient-reported outcomes and quality-of-life.
![Figure 4. Venn diagrams of areas of impact of the prioritized research questions in each focused research domain a. Lifespan sex biology b. Pregnancy and the post-partum context c. Uterine physiology and bleeding research questions d. Bone and joint health e. Health care delivery f. Patient-reported outcomes and quality-of-life.](/cms/asset/93c8dc69-471d-45ee-9a85-4616a9e259be/ierr_a_2175660_f0004_c.jpg)
Table 2. Priority research questions in each focused research domain of the health of people who have or had the potential to menstruate, and their total feasibility-impact-risk score.
Table 3. Examples of potential collaborators in efforts to overcome barriers to important research to advance the health of people who have or had the potential to menstruate with inherited bleeding disorders.